Müller. Christian S G CS; Huff. Thomas T; Hannappel. Ewald E
In a lab study, a drug called araC caused human leukemia cells to die, and as they did, the levels of a small protein called thymosin‑beta‑4 and the building block actin both fell dramatically, along with their mRNA messages. This shows that during cell death, the cells stop making these proteins, but the experiment was done in cell culture, not people.
Feinberg. J J; Heitz. F F; Benyamin. Y Y; Roustan. C C
The study shows that a short piece of the protein thymosin‑beta‑4 (amino acids 5‑20) is floppy in water but folds into a helix when mixed with a lab chemical called TFE, and this folded shape sticks to single actin molecules much better. The chemical doesn’t change actin itself.
Jonckheere. V V; Lambrechts. A A; Vandekerckhove. J J; Ampe. C C
The study shows that a small peptide from the protein VASP can stick to another protein called profilin II, forming a dimer that cancels out the normal slowdown of actin building caused by profilin II and thymosin‑beta‑4, but this effect only happens in a test‑tube setting and doesn’t translate into a clear health or performance protocol.
Scientists mapped the exact 43‑amino‑acid sequence of a calf thymus peptide called thymosin beta‑4, noted its size and that its start is blocked by an acetyl group, and showed it can turn on an enzyme linked to early immune cell development in mice.
Manly. Lester S LS; Roberts. Anne M AM; Beckman. Joseph S JS; Roberts. Blaine R BR
The paper describes a fancy mass‑spectrometry technique that can read the exact sequence and tiny chemical changes of small proteins, including thymosin‑beta‑4, but it doesn’t give any advice on how to use the peptide for health or performance.
Möhring. Thomas T; Kellmann. Markus M; Jürgens. Michael M; Schrader. Michael M
Scientists showed a new, efficient way to spot tiny proteins like thymosin‑beta‑4 directly in brain tissue and spinal fluid using advanced mass‑spectrometry, but the study doesn’t give any dosage or usage tips for people.
Plavina. Tatiana T; Hincapie. Marina M; Wakshull. Eric E; Subramanyam. Meena M; Hancock. William S W...
The study found that people with psoriasis have higher levels of certain cell‑structure proteins and their tiny fragments, including pieces of the peptide thymosin‑beta‑4, in their blood. This likely reflects skin cell damage and increased protein breakdown, not a health‑boosting effect you can copy with supplements.
Giehl. K K; Valenta. R R; Rothkegel. M M; Ronsiek. M M; Mannherz. H G HG; Jockusch. B M BM
Scientists found that a plant protein called birch profilin can stick to animal actin proteins in a way similar to animal profilin, and it competes with the peptide thymosin‑beta‑4 for the same spot on actin. The binding is weak (micromolar) and depends on magnesium, but the study is mostly basic science and doesn’t give any direct health or performance tips.
Scientists made tiny clusters of actin proteins and found that each type changes how actin filaments grow, and they interact differently with proteins like gelsolin, formins, Arp2/3, and the peptide thymosin‑β4. The findings are mostly basic cell‑biology and don’t give clear steps you can use in a health‑oriented routine.
Yarmola. E G EG; Edison. A S AS; Lenox. R H RH; Bubb. M R MR
The study shows that a protein called MARCKS has two spots that bind to actin, and these spots compete with the natural peptide thymosin‑beta‑4 for binding, but the work is purely mechanistic and doesn’t give any direct advice on using thymosin‑beta‑4 as a supplement.
Choudry. Fizzah A FA; Yeo. Chia C; Mozid. Abdul A; Martin. John F JF; Mathur. Anthony A
In a tiny study of people with chronic heart failure, injecting bone‑marrow stem cells into the heart caused a short‑term rise in a natural protein called thymosin‑beta‑4, and those who showed the biggest rise also felt less short‑of‑breath. The work is early and uses a surgical procedure, so it doesn’t give a clear way for everyday health‑hackers to use the peptide.
Scientists made a new tweak to the electrospray ionization tool that lets them change how many electric charges a peptide carries when it’s measured, simply by adjusting the voltage. This makes the mass‑spectrometry readout simpler, showing mostly single‑charged peptide ions and fewer confusing extra signals. While it’s a neat technical improvement for labs, it doesn’t change how you would take or use thymosin‑beta‑4‑fragment in everyday biohacking.
Researchers discovered that rats have many thymosin‑beta‑4‑like sequences that are retroposons (no introns) and one regular gene with two introns and a promoter, showing how the gene is organized but giving no clues for using the peptide in humans.
Scientists figured out the exact makeup of a tiny protein called thymosin beta‑4, including its size, charge, and that it has an acetyl group at the start. They showed it can boost a specific enzyme in mouse immune cells and can slow down macrophage movement, but they didn’t test it in people or give any usage guidelines.
Shimamura. R R; Kudo. J J; Kondo. H H; Dohmen. K K; Gondo. H H; Okamura. S S; Ishibashi. H H; Niho....
This study looked at how the gene for thymosin‑beta‑4 behaves in blood‑cancer cells and found it turns on more when those cells start to change into more mature types, especially in certain T‑cell cancers.
Janmey. P A PA; Lamb. J J; Allen. P G PG; Matsudaira. P T PT
The study looked at short lab‑made pieces of two proteins (gelsolin and villin) that can stick to certain cell‑membrane fats called phosphoinositides. These pieces can pull the fats away from the full proteins, letting the proteins cut actin filaments again. The natural peptide thymosin‑beta‑4 was tested but showed much weaker effects, meaning it isn’t a good stand‑in for these specially designed peptides.
Erickson-Viitanen. S S; Ruggieri. S S; Natalini. P P; Horecker. B L BL
Scientists found a new peptide called thymosin beta 10 that is similar to the well‑known thymosin beta 4. It is present in many animal tissues at very low levels, but the study only describes its structure and where it’s found, not what it does or how to use it.
The paper explains how the protein thymosin beta‑4 is chemically modified inside the body (acetylation, phosphorylation, cross‑linking, and cutting into smaller pieces). It points out that we still don’t know how much of these modified forms exist in cells or what they actually do, and that a fragment of the protein is higher in people with rheumatoid arthritis.
Scientists found a new version of the peptide thymosin‑beta, called thymosin beta‑14, in sea urchins. It’s a small protein of 40 amino acids that looks a lot like the well‑known thymosin beta‑4 from mammals, but the study only describes its structure, not any health effects.
Scientists tested a short piece of the human protein thymosin‑beta‑4 and found it can kill some bacteria and stop them from forming protective biofilms in lab dishes, but only at relatively high concentrations and only in test‑tube experiments.